home / stock / cemi / cemi news

CEMI News and Press, Chembio Diagnostics Inc.

Stock Information
Company Name: Chembio Diagnostics Inc.
Stock Symbol: CEMI
Market: NASDAQ
Website: chembio.com
Menu
CEMI CEMI Quote CEMI Short CEMI News CEMI Articles CEMI Message Board
Get CEMI Alerts

News, Short Squeeze, Breakout and More Instantly...
CEMI - Biosynex Completes Acquisition of Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of ...
CEMI - Chembio Stockholders Urged to Tender Shares Before 6:00 P.M., New York City Time, on April 26, 2023

MEDFORD, N.Y., April 19, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 19, 2023 ...

CEMI - Biosynex again extends tender offer for Chembio acquisition

2023-04-13 07:37:12 ET Biosynex has extended the tender offer to acquire Chembio Diagnostics ( NASDAQ: CEMI ) once again, this time to April 26, from April 12. Biosynex noted that as of April 12, ~17.74M shares were tendered , representing ~48.3% of the outstanding stock. ...

CEMI - Chembio Stockholders Reminded to Tender Shares Before 6:00 P.M., New York City Time, on April 12, 2023

MEDFORD, N.Y., April 10, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 10, 2023 ...
CEMI - Chembio's CEO Letter to Stockholders

MEDFORD, N.Y., April 03, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. April 3, 2023 F...

CEMI - Biosynex extends tender offer period for Chembio acquisition

2023-03-29 07:57:16 ET Biosynex extended the tender offer to acquire Chembio Diagnostics ( NASDAQ: CEMI ) to April 12, from March 28. France-based Biosynex said that as of March 28, ~14.13M Chembio shares were tendered , representing ~38.5% of the outsta...

CEMI - Chembio Stockholders Reminded to Tender Shares Before 6:00 PM New York City Time, on March 28, 2023

MEDFORD, N.Y., March 21, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. Fellow Chembio Stockh...
CEMI - Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.

STRASBOURG, France, March 15, 2023 (GLOBE NEWSWIRE) -- Biosynex SA (“Biosynex”) (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, today announced that Project Merci Merger Sub, Inc. (“Purchaser”), a Nevada corporation and ...

CEMI - Chembio Announces Letter to Stockholders Regarding Tender Offer

MEDFORD, N.Y., March 15, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today released the following letter to stockholders concerning the pending tender offer by Biosynex SA. March 15, 2023 ...

CEMI - Chembio Announces the Receipt of CLIA Waiver for its DPP HIV-Syphilis System

MEDFORD, N.Y., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt of a Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administrat...
Next 10